Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06246526 · ClinicalTrials.gov registry record · NA

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

A NA study of Pain and Chronic Pain, sponsored by Saint Francis Hospital.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06246526: Active NA study of Pain and Chronic Pain, sponsored by Saint Francis Hospital.

NCT06246526 is a NA study of Pain and Chronic Pain that is active but no longer recruiting, run by Saint Francis Hospital. The registered enrollment target is 25 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06246526, a NA study of Pain and Chronic Pain, is active but no longer recruiting, sponsored by Saint Francis Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This observational, prospective data collection is designed to evaluate the efficacy of CL-SCS therapy in real-world patients suffering from chronic pain.

Interventions

  • DEVICE Evoke

Study Locations (1)

West Virginia

  • The Spine and Nerve Center of Saint Francis Hospital - Charleston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-01-30
Est. Completion 2026-12-31
Phase NA
Saint Francis Hospital

3 total trials

What the registry record for NCT06246526 still lists

NCT06246526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Evoke is the first listed.

NCT06246526 reports a single indexed study location in West Virginia.

Frequently Asked Questions

What is clinical trial NCT06246526 about?

NCT06246526 is a clinical study titled "Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).". This observational, prospective data collection is designed to evaluate the efficacy of CL-SCS therapy in real-world patients suffering from chronic pain.

What is the current status of trial NCT06246526?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-01-30. Estimated completion is 2026-12-31.

What conditions does trial NCT06246526 study?

This clinical trial studies the following conditions: Pain, Chronic Pain, Neuropathic Pain.

What interventions are being tested in trial NCT06246526?

The interventions under investigation include: Evoke (DEVICE).

Who is sponsoring clinical trial NCT06246526?

This trial is sponsored by Saint Francis Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06246526 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06246526's enrollment target sits among peer trials

25 321st of 374 higher than 51 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06246526, the US trial registry maintained by the National Library of Medicine. NCT06246526 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.